Last reviewed · How we verify
anti-CTLA-4 antibody
At a glance
| Generic name | anti-CTLA-4 antibody |
|---|---|
| Also known as | ipilimumab, Yervoy, BMS-734016 |
| Sponsor | Intensity Therapeutics, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- anti-CTLA-4 antibody CI brief — competitive landscape report
- anti-CTLA-4 antibody updates RSS · CI watch RSS
- Intensity Therapeutics, Inc. portfolio CI